EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

Long-Term Outcomes of Brugada Substrate Ablation: A Report from BRAVO (Brugada Ablation of VF Substrate Ongoing Multicenter Registry)

Koonlawee Nademanee iD, Fa-Po Chung, Frederic Sacher iD, Akihiko Nogami, Hiroshi Nakagawa iD, Chenyang Jiang, Meleze Hocini iD, Elijah Behr iD, Gumpanart Veerakul, Jaap Jan Smit, Arthur A M Wilde iD, Shih-Ann Chen iD und 7 weitere

Circulation · 23.05.2023 · 147 (21) · 1568-1578

DOI: 10.1161/circulationaha.122.063367 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Circulation, erschienen am 23.05.2023. Verfasst von Koonlawee Nademanee und 18 weiteren Autor:innen. Beteiligte Einrichtung: Center of Excellence in Arrhythmia Research and Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand (K.N., A.K.,…. Hauptthemen laut MEDLINE: Brugada Syndrome, Defibrillators, Implantable, Catheter Ablation. Die Arbeit wurde bisher 82-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Treatment options for high-risk Brugada syndrome (BrS) with recurrent ventricular fibrillation (VF) are limited. Catheter ablation is increasingly performed but a large study with long-term outcome data is lacking. We report the results of the multicenter, international BRAVO (Brugada Ablation of VF Substrate Ongoing Registry) for treatment of high-risk symptomatic BrS.

Methods

We enrolled 159 patients (median age 42 years; 156 male) with BrS and spontaneous VF in BRAVO; 43 (27%) of them had BrS and early repolarization pattern. All but 5 had an implantable cardioverter-defibrillator for cardiac arrest (n=125) or syncope (n=34). A total of 140 (88%) had experienced numerous implantable cardioverter-defibrillator shocks for spontaneous VF before ablation. All patients underwent a percutaneous epicardial substrate ablation with electroanatomical mapping except for 8 who underwent open-thoracotomy ablation.

Results

In all patients, VF/BrS substrates were recorded in the epicardial surface of the right ventricular outflow tract; 45 (29%) patients also had an arrhythmic substrate in the inferior right ventricular epicardium and 3 in the posterior left ventricular epicardium. After a single ablation procedure, 128 of 159 (81%) patients remained free of VF recurrence; this number increased to 153 (96%) after a repeated procedure (mean 1.2±0.5 procedures; median=1), with a mean follow-up period of 48±29 months from the last ablation. VF burden and frequency of shocks decreased significantly from 1.1±2.1 per month before ablation to 0.003±0.14 per month after the last ablation ( P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brugada SyndromeDefibrillators, ImplantableCatheter AblationHumansMaleAdultVentricular FibrillationElectrocardiographyHeart VentriclesRegistriesNitriles

Stichwörter der Autor:innen

Brugada syndromechannelopathiesdeath, suddendefibrillators, implantableventricular fibrillation

Substanzen

tetrachloroisophthalonitrileNitriles

Autor:innen und Institutionen

  • Center of Excellence in Arrhythmia Research and Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand (K.N., A.K., S.V.).
  • Pacific Rim Electrophysiology Research Institute at Bumrungrad Hospital, Bangkok, Thailand (K.N.).
  • Heart Rhythm Center, Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taiwan (F.-P.C., S.-A.C.).
  • National Yang-Ming Chiao-Tung University School of Medicine, Taipei, Taiwan (F.-P.C., S.-A.C.).
  • Cardiac Arrhythmia Department, Bordeaux University Hospital, LIRYC Institute, Université Bordeaux, France (F.S., M. Hocini, M. Haissaguerre).
  • University of Tsukuba, Division of Cardiology, Ibaraki, Japan (A.N.).

ORCID-Profile: Koonlawee Nademanee, Frederic Sacher, Hiroshi Nakagawa, Meleze Hocini, Elijah Behr, Arthur A M Wilde, Shih-Ann Chen, Itsuro Morishima, Apichai Khongphatthanayothin, Michel Haissaguerre

Zitieren

APA

Nademanee, K., Chung, F. P., Sacher, F., Nogami, A., Nakagawa, H., Jiang, C., Hocini, M., Behr, E., Veerakul, G., Jan Smit, J., Wilde, A. A. M., Chen, S. A., Yamashiro, K., Sakamoto, Y., Morishima, I., Das, M. K., Khongphatthanayothin, A., Vardhanabhuti, S., & Haissaguerre, M. (2023). Long-Term Outcomes of Brugada Substrate Ablation: A Report from BRAVO (Brugada Ablation of VF Substrate Ongoing Multicenter Registry). Circulation, 147(21), 1568-1578. https://doi.org/10.1161/circulationaha.122.063367

Vancouver

Nademanee K, Chung FP, Sacher F, Nogami A, Nakagawa H, Jiang C, et al. Long-Term Outcomes of Brugada Substrate Ablation: A Report from BRAVO (Brugada Ablation of VF Substrate Ongoing Multicenter Registry). Circulation. 2023;147(21):1568-1578. doi:10.1161/circulationaha.122.063367

BibTeX
@article{Nademanee2023,
  author = {Nademanee, Koonlawee and Chung, Fa-Po and Sacher, Frederic and Nogami, Akihiko and Nakagawa, Hiroshi and Jiang, Chenyang and Hocini, Meleze and Behr, Elijah and Veerakul, Gumpanart and Jan Smit, Jaap and Wilde, Arthur A M and Chen, Shih-Ann and Yamashiro, Kohei and Sakamoto, Yuichiro and Morishima, Itsuro and Das, Mithilesh K and Khongphatthanayothin, Apichai and Vardhanabhuti, Saran and Haissaguerre, Michel},
  title = {Long-Term Outcomes of Brugada Substrate Ablation: A Report from BRAVO (Brugada Ablation of VF Substrate Ongoing Multicenter Registry)},
  journal = {Circulation},
  year = {2023},
  volume = {147},
  number = {21},
  pages = {1568--1578},
  doi = {10.1161/circulationaha.122.063367}
}
Kostenlos starten →